ALLK
Price
$1.11
Change
-$0.00 (-0.00%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
100.06M
40 days until earnings call
HOWL
Price
$1.36
Change
-$0.00 (-0.00%)
Updated
Jan 22 closing price
Capitalization
60.61M
56 days until earnings call
Ad is loading...

ALLK vs HOWL

Header iconALLK vs HOWL Comparison
Open Charts ALLK vs HOWLBanner chart's image
Allakos
Price$1.11
Change-$0.00 (-0.00%)
Volume$988
Capitalization100.06M
Werewolf Therapeutics
Price$1.36
Change-$0.00 (-0.00%)
Volume$192.64K
Capitalization60.61M
ALLK vs HOWL Comparison Chart
Loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLK vs. HOWL commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Hold and HOWL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (ALLK: $1.12 vs. HOWL: $1.36)
Brand notoriety: ALLK and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 86% vs. HOWL: 52%
Market capitalization -- ALLK: $100.06M vs. HOWL: $60.61M
ALLK [@Biotechnology] is valued at $100.06M. HOWL’s [@Biotechnology] market capitalization is $60.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, ALLK is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 3 TA indicator(s) are bullish while HOWL’s TA Score has 2 bullish TA indicator(s).

  • ALLK’s TA Score: 3 bullish, 4 bearish.
  • HOWL’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ALLK is a better buy in the short-term than HOWL.

Price Growth

ALLK (@Biotechnology) experienced а +29.09% price change this week, while HOWL (@Biotechnology) price change was -2.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

ALLK is expected to report earnings on May 07, 2025.

HOWL is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLK($100M) has a higher market cap than HOWL($60.6M). ALLK YTD gains are higher at: -7.438 vs. HOWL (-8.108). HOWL has higher annual earnings (EBITDA): -55.89M vs. ALLK (-154.72M). HOWL has more cash in the bank: 123M vs. ALLK (92.7M). HOWL has less debt than ALLK: HOWL (36.8M) vs ALLK (39M). HOWL has higher revenues than ALLK: HOWL (3.39M) vs ALLK (0).
ALLKHOWLALLK / HOWL
Capitalization100M60.6M165%
EBITDA-154.72M-55.89M277%
Gain YTD-7.438-8.10892%
P/E RatioN/AN/A-
Revenue03.39M-
Total Cash92.7M123M75%
Total Debt39M36.8M106%
FUNDAMENTALS RATINGS
ALLK: Fundamental Ratings
ALLK
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLKHOWL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 16 days ago
86%
Bearish Trend 16 days ago
87%
Momentum
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 16 days ago
88%
MACD
ODDS (%)
Bearish Trend 16 days ago
75%
Bullish Trend 16 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 16 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 16 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 16 days ago
89%
Bearish Trend 16 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNNAF0.02N/A
+4.17%
SIENNA RESOURCES INC
FTCO5.230.10
+1.95%
Fortitude Gold Corporation
TRMLF48.180.25
+0.52%
Tourmaline Oil Corp.
YAMCY6.680.02
+0.31%
Yamaha Corp.
BASFY11.73-0.16
-1.30%
BASF SE

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with GNPX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
+0.90%
GNPX - ALLK
38%
Loosely correlated
+8.17%
AXON - ALLK
38%
Loosely correlated
+0.33%
AKBA - ALLK
36%
Loosely correlated
+0.84%
ENSC - ALLK
35%
Loosely correlated
+3.50%
OMGA - ALLK
35%
Loosely correlated
-5.00%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
N/A
GBIO - HOWL
37%
Loosely correlated
-3.45%
AURA - HOWL
36%
Loosely correlated
N/A
ABOS - HOWL
35%
Loosely correlated
+7.36%
ALLK - HOWL
35%
Loosely correlated
+0.90%
KRRO - HOWL
34%
Loosely correlated
+1.33%
More